HYPOTHALAMIC OBESITY
Clinical trials for HYPOTHALAMIC OBESITY explained in plain language.
Never miss a new study
Get alerted when new HYPOTHALAMIC OBESITY trials appear
Sign up with your email to follow new studies for HYPOTHALAMIC OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a diabetes drug tame obesity caused by brain tumor treatment?
Disease control CompletedThis study tested whether exenatide, a diabetes drug, plus lifestyle changes helps adults with severe weight gain after treatment for a rare brain tumor (craniopharyngioma). 42 adults aged 18-75 took either exenatide or a placebo for 6 months. The main goal was to see if they los…
Matched conditions: HYPOTHALAMIC OBESITY
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New pill targets hard-to-treat obesity after brain injury
Disease control CompletedThis study tested an experimental daily pill, LB54640, in 28 people aged 12 and older with hypothalamic obesity—a condition where brain injury causes rapid, severe weight gain. For the first 14 weeks, some received the drug and some a placebo to see if it safely reduces weight an…
Matched conditions: HYPOTHALAMIC OBESITY
Phase: PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC